Is it necessary to use tislelizumab?
Feb 28, 2023
Source: Cainiu Health
Dr. You Zhangxuan
Introduction
Tislelizumab is indicated and commonly used for advanced malignancies such as Hodgkin's lymphoma, urothelial carcinoma, and hepatocellular carcinoma. It helps control cancer progression and improves patients' quality of life. Tislelizumab directly targets vascular endothelial growth factor (VEGF) and belongs to the class of immunological targeted drugs. It is usually administered intravenously and can prevent the formation of vascular endothelial growth factor.
Generally, tislelizumab is necessary and commonly used for advanced malignant tumors, such as Hodgkin's lymphoma, urothelial carcinoma, hepatocellular carcinoma, etc., effectively controlling cancer progression and improving patients' quality of life. The detailed analysis is as follows:
Tislelizumab directly targets vascular endothelial growth factor (VEGF) and belongs to the class of immunological targeted drugs. It is usually administered intravenously, inhibiting the formation of VEGF and preventing tumor angiogenesis, thereby achieving tumor suppression. Tislelizumab has a broad range of indications and can be used for recurrent cases after second-line systemic chemotherapy, as well as in the treatment of Hodgkin's lymphoma, urothelial carcinoma, hepatocellular carcinoma, among others. After administration, most patients experience alleviation or stabilization of clinical symptoms and may continue treatment. However, if the disease continues to progress despite treatment, the drug should be discontinued.
Some patients may experience adverse reactions after taking tislelizumab, including fever, decreased white blood cell count, itching, and hypothyroidism. However, due to individual differences in patient constitution, adverse reactions may vary. To avoid potential harm to the body, it is recommended that the medication be used under the guidance of a qualified physician.
